D-Cateslytin: a new antifungal agent for the treatment of oral Candida albicans associated infections
Abstract The excessive use of antifungal agents, compounded by the shortage of new drugs being introduced into the market, is causing the accumulation of multi-resistance phenotypes in many fungal strains. Consequently, new alternative molecules to conventional antifungal agents are urgently needed...
Enregistré dans:
Auteurs principaux: | Pauline Dartevelle, Claire Ehlinger, Abdurraouf Zaet, Christian Boehler, Morgane Rabineau, Benoit Westermann, Jean-Marc Strub, Sarah Cianferani, Youssef Haïkel, Marie-Hélène Metz-Boutigue, Céline Marban |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/6542be9b5ef34063b0fd3b1f1dd72f6f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Catestatin in innate immunity and Cateslytin-derived peptides against superbugs
par: Francesco Scavello, et autres
Publié: (2021) -
Strongly Adhesive and Antimicrobial Peptide-Loaded, Alginate–Catechol-Based Gels for Application against Periimplantitis
par: Sébastien Baixe, et autres
Publié: (2021) -
IN VITRO ANTIFUNGAL ACTIVITY OF POTASH ALUM AGAINST CANDIDA ALBICANS ON ACRYLIC RESIN
par: Muhammad Irshad, et autres
Publié: (2020) -
Mechanisms of the antifungal action of marine metagenome-derived peptide, MMGP1, against Candida albicans.
par: Muthuirulan Pushpanathan, et autres
Publié: (2013) -
Antifungal Effects and Potential Mechanisms of Benserazide Hydrochloride Alone and in Combination with Fluconazole Against Candida albicans
par: Chen X, et autres
Publié: (2021)